Orion Oyj (HEL:ORNBV), a company engaged in the development, manufacture and marketing of pharmaceuticals and diagnostic tests, announced on Wednesday changes in the responsibility areas of the company's executive management board.

Reportedly, these changes are aimed at accelerating growth and bringing positive effects on the successful development of the company.

Under these changes, as of 1 October 2018, Markku Huhta-Koivisto, SVP, Proprietary Products business division, will take the responsibility for projects aiming at Orion's growth, as SVP, Growth Projects. Reportedly, Huhta-Koivisto's area of responsibility is a new one in Orion.

Satu Ahomäki, SVP, Global Sales will, in addition to her current area of responsibility of sales of human pharmaceuticals, take the responsibility for Proprietary Products business division. This responsibility area of Ahomäki will be named as Commercial Operations.

As of 1 January 2019 Dr. Liisa Hurme, SVP, Specialty Products and Fermion, will take the responsibility for Supply Chain line function. In addition, Fermion business division will still belong to Dr. Hurme's responsibility area. Virve Laitinen, SVP, Supply Chain, will take the responsibility for Specialty Products business division.